Hospital
Shelby County Memorial Hospital Association INC.
Shelby County Memorial Hospital Association INC. was paid $10.64M by Medicaid between Jan 2018 and Dec 2024, across 230 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoSHELBY COUNTY MEMORIAL HOSPITAL ASSOCIATION INC.
SIDNEY, OH 45365
SIDNEY, OH 45365
33aNPI1639174204assigned 06/20/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.64M
24GClaims306,313
24DCodes billed230
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#75 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,168 | $1.11M | |
| 2019 | 21,027 | $843K | |
| 2020 | 16,641 | $902K | |
| 2021 | 16,818 | $820K | |
| 2022 | 16,713 | $697K | |
| 2023 | 117,738 | $3.68M | |
| 2024incomplete | 83,208 | $2.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 18,391 | 17,090 | $2.07M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 13,108 | 11,812 | $1.54M |
| 96361 | Intravenous infusion, hydration; each additional hour | 13% | 5,103 | 3,900 | $1.39M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 8,836 | 7,717 | $1.11M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 3,571 | 1,082 | $269K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 998 | 823 | $240K |
| 80053 | Comprehensive metabolic panel | 2.2% | 19,844 | 17,025 | $236K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 747 | 595 | $198K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 754 | 629 | $189K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.4% | 1,667 | 1,017 | $149K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 3,505 | 3,197 | $149K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.4% | 796 | 637 | $144K |
218 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 1,368 | $129K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 1,121 | $109K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 738 | $100K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 462 | $98K |
| 81513 | <1% | 641 | $95K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 836 | $91K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 870 | $88K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 3,492 | $87K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,709 | $85K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,347 | $75K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 40 | $74K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,165 | $73K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 23,779 | $70K |
| G0378 | Hospital observation service, per hour | <1% | 907 | $69K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,297 | $68K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 338 | $56K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 133 | $56K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,716 | $53K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,838 | $53K |
| 87070 | <1% | 2,176 | $50K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 231 | $47K |
| 80061 | Lipid panel | <1% | 3,616 | $46K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,136 | $43K |
| 84439 | <1% | 1,826 | $42K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 22,651 | $38K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,891 | $36K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 131 | $33K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 737 | $33K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,292 | $33K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,458 | $33K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,921 | $32K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,658 | $32K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 915 | $32K |
| 87480 | <1% | 1,433 | $30K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,206 | $29K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 294 | $28K |
| 84702 | <1% | 1,489 | $28K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 103 | $28K |
| 87481 | <1% | 643 | $26K | |
| 76830 | Ultrasound, transvaginal | <1% | 239 | $25K |
| 84144 | <1% | 732 | $25K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 476 | $24K |
| 87510 | <1% | 1,432 | $23K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 426 | $22K |
| 93017 | <1% | 268 | $21K | |
| 74018 | <1% | 471 | $21K | |
| 87088 | <1% | 2,362 | $20K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,538 | $19K |
| 87660 | <1% | 1,403 | $18K | |
| 87653 | <1% | 340 | $17K | |
| 86787 | <1% | 478 | $17K | |
| 87077 | <1% | 1,312 | $16K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 804 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,409 | $16K |
| 97162 | <1% | 222 | $14K | |
| 86592 | <1% | 389 | $14K | |
| 84484 | <1% | 3,354 | $14K | |
| 72100 | <1% | 346 | $13K | |
| 82607 | <1% | 818 | $12K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 737 | $12K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 109 | $12K |
| 97161 | <1% | 331 | $11K | |
| 80055 | <1% | 398 | $10K | |
| 73630 | <1% | 559 | $10K | |
| 82728 | <1% | 491 | $10K | |
| 86850 | <1% | 470 | $10K | |
| 83735 | <1% | 2,851 | $9K | |
| 82950 | <1% | 578 | $9K | |
| 86803 | <1% | 440 | $8K | |
| 82570 | <1% | 822 | $8K | |
| J3490 | Unclassified drugs | <1% | 2,278 | $8K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 355 | $8K |
| 87186 | <1% | 1,211 | $8K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,693 | $7K |
| 73564 | <1% | 381 | $7K | |
| 01999 | <1% | 2,222 | $7K | |
| 86140 | <1% | 637 | $7K | |
| 83540 | <1% | 555 | $7K | |
| 73610 | <1% | 399 | $6K | |
| 86900 | <1% | 490 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 319 | $5K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 28 | $5K |
| 94060 | <1% | 51 | $5K | |
| 86696 | <1% | 311 | $5K | |
| 71250 | <1% | 55 | $5K | |
| 85027 | <1% | 732 | $5K | |
| 85014 | <1% | 419 | $5K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 426 | $5K |
| 86695 | <1% | 311 | $4K | |
| 84481 | <1% | 272 | $4K | |
| 73130 | <1% | 351 | $4K | |
| 85610 | <1% | 1,556 | $4K | |
| 83550 | <1% | 383 | $4K | |
| 0011A | <1% | 136 | $4K | |
| 82565 | <1% | 444 | $4K | |
| 73030 | <1% | 204 | $4K | |
| 87147 | <1% | 487 | $4K | |
| 0012A | <1% | 107 | $4K | |
| 84403 | <1% | 187 | $4K | |
| 85652 | <1% | 652 | $4K | |
| 76642 | <1% | 25 | $4K | |
| 84480 | <1% | 176 | $3K | |
| 82043 | <1% | 491 | $3K | |
| 96367 | <1% | 98 | $3K | |
| 81001 | <1% | 1,953 | $3K | |
| 82746 | <1% | 587 | $3K | |
| 85018 | <1% | 465 | $3K | |
| 84156 | <1% | 391 | $3K | |
| 84146 | <1% | 103 | $2K | |
| 80076 | <1% | 178 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 34 | $2K |
| 83690 | <1% | 3,296 | $2K | |
| 83880 | <1% | 550 | $2K | |
| 86901 | <1% | 490 | $2K | |
| 81003 | <1% | 2,554 | $2K | |
| A0425 | Ground mileage, per statute mile | <1% | 129 | $2K |
| 84550 | <1% | 288 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 13 | $2K |
| 97597 | <1% | 22 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 648 | $2K |
| 81015 | <1% | 3,110 | $2K | |
| 81025 | <1% | 3,995 | $2K | |
| 82247 | <1% | 104 | $2K | |
| 82805 | <1% | 49 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,612 | $2K |
| 80081 | <1% | 51 | $2K | |
| 87340 | <1% | 55 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,852 | $1K |
| 84450 | <1% | 169 | $1K | |
| 82077 | <1% | 772 | $1K | |
| 0064A | <1% | 35 | $1K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 13 | $1K |
| 84460 | <1% | 161 | $1K | |
| 84153 | <1% | 69 | $1K | |
| 94726 | <1% | 23 | $1K | |
| 94729 | <1% | 22 | $1K | |
| 83605 | <1% | 721 | $1K | |
| 87205 | <1% | 184 | $988.52 | |
| 84436 | <1% | 260 | $985.93 | |
| 86038 | <1% | 29 | $971.57 | |
| 72072 | <1% | 18 | $970.09 | |
| 96376 | <1% | 728 | $952.77 | |
| 83655 | <1% | 40 | $948.55 | |
| 80074 | <1% | 25 | $863.43 | |
| 82670 | <1% | 27 | $814.52 | |
| 85730 | <1% | 627 | $791.61 | |
| 82105 | <1% | 29 | $790.07 | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 37 | $789.60 |
| 73110 | <1% | 74 | $783.67 | |
| 83970 | <1% | 19 | $666.02 | |
| 73502 | <1% | 27 | $661.94 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,138 | $570.32 |
| 85379 | <1% | 467 | $569.13 | |
| 82248 | <1% | 81 | $534.69 | |
| 84100 | <1% | 123 | $507.55 | |
| 88142 | <1% | 24 | $465.81 | |
| 0001A | <1% | 28 | $448.10 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 56 | $372.77 |
| 83001 | <1% | 17 | $333.52 | |
| 88141 | <1% | 12 | $306.68 | |
| 85007 | <1% | 35 | $301.17 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,210 | $270.55 |
| 82951 | <1% | 12 | $252.23 | |
| 82947 | <1% | 16 | $239.46 | |
| 80329 | <1% | 163 | $212.17 | |
| 94760 | <1% | 3,402 | $198.30 | |
| 86704 | <1% | 14 | $197.40 | |
| 73080 | <1% | 12 | $194.22 | |
| 86706 | <1% | 12 | $171.08 | |
| 82952 | <1% | 12 | $163.35 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,761 | $159.47 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 591 | $155.27 |
| 87040 | <1% | 151 | $152.36 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,266 | $144.08 |
| 83615 | <1% | 28 | $134.03 | |
| 80143 | <1% | 248 | $122.17 | |
| 82550 | <1% | 31 | $109.69 | |
| 82150 | <1% | 72 | $77.82 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,227 | $71.08 |
| J0280 | Injection, aminophyllin, up to 250 mg | <1% | 15 | $70.38 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,185 | $53.05 |
| A9270 | Non-covered item or service | <1% | 3,481 | $46.25 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,725 | $45.76 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 112 | $42.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 679 | $36.53 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 123 | $26.64 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 875 | $26.27 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,509 | $20.80 |
| 88342 | <1% | 28 | $20.69 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,542 | $20.17 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 782 | $15.48 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 210 | $15.38 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 176 | $11.45 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 255 | $10.64 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,078 | $8.83 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 16 | $5.38 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 322 | $3.92 |
| 91301 | <1% | 253 | $2.32 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 77 | $1.70 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 458 | $1.20 |
| 91300 | <1% | 68 | $0.60 | |
| 91306 | <1% | 35 | $0.33 | |
| 94761 | 0% | 3,482 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 134 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 179 | $0.00 |
| 82962 | 0% | 69 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 205 | $0.00 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 0% | 85 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 35 | $0.00 |
| J8501 | Aprepitant, oral, 5 mg | 0% | 16 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 76 | $0.00 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 19 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 72 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 29 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 14 | $0.00 |
| 36600 | 0% | 17 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 15 | $0.00 |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 0% | 44 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOVAULT, JULIE (VP FINANCIAL SERVICE)
| Provider | Location | Paid |
|---|---|---|
| Wilson Care, LLC | Sidney, OH | $5.56M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.